An investigation on behalf of investors in scPharmaceuticals Inc. (NASDAQ: SCPH) shares over potential wrongdoing at scPharmaceuticals Inc. was announced.
San Diego, CA -- (SBWIRE) -- 09/05/2019 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at scPharmaceuticals Inc.
Investors who purchased shares of scPharmaceuticals Inc. (NASDAQ: SCPH) and currently hold any of those NASDAQ: SCPH shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain scPharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.
Burlington, MA based scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. scPharmaceuticals Inc. went public in November 2017 and sold 6,400,000 shares of common stock at a public offering price of $14.00 per share, for gross proceeds of $89.6 million. Since then shares of scPharmaceuticals Inc. (NASDAQ: SCPH) declined to as low as $4.09 per share on October 23, 2018.
Those who purchased shares of scPharmaceuticals Inc. (NASDAQ: SCPH) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels